We at TIEFEENBACHER PHARMACEUTICALS strongly believe that our high-quality medicines should be affordable for all patients irrespective of their income level or nationality. That´s why Tiefenbacher Pharmaceuticals is excited to share that the launch of the first generic version of Bilastine (20 mg tablets) in Spain was a total success.

Bilastine is an innovative anti-allergy medicine improving the life of patients suffering from allergic symptoms, such as hay fever and urticaria. The second-generation antihistamine product helps to relieve nasal and non-nasal symptoms of seasonal rhinitis (like sneezing and red, streaming eyes) as well as urticaria caused symptoms (like itchy skin).

With this generic market entry TIEFENBACHER PHARMACEUTICALS achieves nameable savings for the international health care systems and enables millions of patients a better affordable access to a life-improving treatment. Following our global market entry approach, a launch in several further international countries is already in preparation.

We will keep you updated about launches of this and other products in further international markets.

For further information about our pharmaceuticals or medical devices please contact TIEFENBACHER PHARMACEUTICALS: info@aet.eu

TIEFENBACHER PHARMACEUTICALS is a part of TIEFENBACHER GROUP – Pioneering Healthcare since 1963. Please visit us on: www.aet.eu and www.tiefenbachergroup.com